Website: AbCellera
Business Area(s):
Description:
Develop therapeutic monoclonal antibodies.
3/12/2020 - AbCellera and Lilly will select from 500+ unique antibodies isolated from one of the first U.S. patients who recovered from COVID-19 to create antibody therapeutics for treatment and prevention of COVID-19
Career Page(s):
Location(s):
Vancouver
Canada
See map: Google Maps